Panel Discussion: Bringing Cosmetic Dermatology Back into R&D & Addressing High Patient Demand Through Scientific Innovation
9:00 am - Thursday 5th November 2026
- Examining why conditions such as acne, female hair loss, skin aging and aesthetic restoration remain underrepresented in dermatology drug development, despite affecting millions of patients worldwide, to identify where innovation is most needed
- Exploring how advances in regenerative medicine, longevity science, muscle restoration, skin rejuvenation and hair biology are creating new opportunities beyond traditional inflammatory dermatology, to unlock the next generation of dermatology pipelines
- Debating how industry, academia and clinicians can elevate cosmetic dermatology from a procedure-driven market to a science-led therapeutic field, strengthening evidence generation, regulatory pathways and investment in high-unmet-need patient populations
